Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Ophthalmic Drug

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1577565

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1577565

Myopia and Presbyopia Treatment

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Myopia and Presbyopia Treatment Market to Reach US$26.3 Billion by 2030

The global market for Myopia and Presbyopia Treatment estimated at US$17.5 Billion in the year 2023, is expected to reach US$26.3 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Myopia Treatment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$16.1 Billion by the end of the analysis period. Growth in the Presbyopia Treatment segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 9.7% CAGR

The Myopia and Presbyopia Treatment market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Myopia and Presbyopia Treatment Market – Key Trends & Drivers Summarized

Why Is the Treatment of Myopia and Presbyopia Gaining Significance Worldwide?

The treatment of myopia and presbyopia is gaining increasing significance worldwide due to the rapid rise in the prevalence of these refractive vision disorders, largely driven by demographic shifts, lifestyle changes, and aging populations. Myopia, or nearsightedness, is one of the most common vision conditions globally, affecting millions of people, particularly younger populations. Its prevalence has been growing rapidly, especially in urbanized regions, due to increased time spent on close-up activities such as reading, screen use, and digital devices. The growing incidence of myopia has raised concerns about the potential for long-term complications, including a higher risk of developing conditions like retinal detachment, cataracts, and glaucoma. This has made the early detection and treatment of myopia a critical focus in ophthalmology.

Presbyopia, on the other hand, is an age-related condition that affects nearly everyone over the age of 40. As global populations age, the demand for effective treatments for presbyopia continues to rise. Presbyopia reduces the ability of the eye to focus on near objects, leading to the widespread use of corrective lenses such as reading glasses, contact lenses, or bifocals. However, advancements in medical technologies have led to new treatment options such as multifocal lenses, refractive surgery, and innovative contact lens designs. The growing emphasis on eye health and the demand for treatments that provide long-term solutions, rather than temporary fixes like glasses, has driven the development of more sophisticated treatments. With myopia becoming an epidemic in many parts of the world and presbyopia affecting aging populations, the need for advanced and accessible treatments is more pressing than ever.

How Are Technological Advancements Revolutionizing Myopia and Presbyopia Treatments?

Technological advancements are revolutionizing the treatment landscape for myopia and presbyopia, offering more effective, longer-lasting, and less invasive solutions than ever before. In the case of myopia, one of the most significant advancements has been the development of orthokeratology (Ortho-K) lenses, which are specially designed contact lenses that reshape the cornea overnight, temporarily correcting vision. This non-invasive method has proven to be an effective treatment for children and young adults with progressive myopia, helping to slow down the worsening of the condition. Additionally, low-dose atropine eye drops have emerged as a promising pharmacological treatment for controlling the progression of myopia in children. By slowing the elongation of the eye, these treatments aim to reduce the risk of high myopia, which can lead to more serious eye health problems later in life.

For presbyopia, advancements in lens technologies and surgical techniques are transforming treatment options. Multifocal and extended depth-of-focus intraocular lenses (IOLs) used in cataract surgery are increasingly being used to correct presbyopia, providing patients with the ability to see at multiple distances without the need for glasses. Additionally, presbyopia-correcting contact lenses, including multifocal and bifocal designs, are becoming more comfortable and effective thanks to innovations in lens materials and designs that improve visual clarity and wearer comfort. Surgical treatments, such as laser-assisted in situ keratomileusis (LASIK) and corneal inlays, are also offering long-term solutions by reshaping the cornea or inserting devices to improve near vision. These cutting-edge treatments are providing patients with greater flexibility and more permanent solutions, reducing dependence on glasses and offering enhanced quality of life.

Moreover, the rise of digital health technologies and artificial intelligence (AI) is further enhancing treatment strategies. AI-driven diagnostic tools are being used to detect early signs of myopia progression and presbyopia, enabling more timely and targeted interventions. Telemedicine platforms are also becoming instrumental in improving access to care, particularly in remote or underserved areas where traditional eye care services may be limited. These technological advancements are not only broadening the range of treatment options available but are also making eye care more personalized, efficient, and accessible.

How Are Shifting Patient Preferences Shaping the Myopia and Presbyopia Treatment Market?

Shifting patient preferences, especially regarding convenience, aesthetics, and lifestyle, are playing a crucial role in shaping the myopia and presbyopia treatment market. In an era where people prioritize comfort and lifestyle adaptability, many patients are looking for treatment solutions that align with their active lifestyles and reduce dependency on traditional corrective measures such as glasses. In the case of myopia, there is a growing demand for treatments that go beyond standard corrective lenses. Parents are increasingly seeking out preventive treatments for their children, such as orthokeratology (Ortho-K) lenses or low-dose atropine eye drops, which can slow the progression of myopia and potentially reduce the need for stronger prescriptions later in life. The ability to reduce or eliminate the need for eyeglasses is particularly appealing for children and young adults engaged in sports or other activities where glasses can be cumbersome.

For presbyopia, many patients are now looking for solutions that provide greater freedom from reading glasses, which are often seen as inconvenient or unattractive. The growing popularity of multifocal contact lenses and advanced intraocular lenses (IOLs) used in cataract surgery is largely driven by patients’ desire for a more permanent and aesthetically pleasing solution to age-related vision decline. These lenses offer the benefit of clear vision at multiple distances without the need for bifocals or reading glasses. Patients are also showing increased interest in surgical options such as LASIK or corneal inlays, which offer long-term correction and eliminate the daily hassle of managing eyewear. Additionally, as technology has advanced, many people now expect treatments to be minimally invasive with short recovery times, further pushing the development of sophisticated, low-risk surgical options for presbyopia correction.

Aesthetic concerns also play a significant role in patient preferences, particularly among younger generations who prioritize appearance and convenience. This has led to a growing interest in treatments that allow for clear vision without the visible use of glasses, making contact lenses, refractive surgeries, and innovative eye drop therapies increasingly popular. These shifting patient preferences are driving the demand for more diverse, customized, and less invasive treatment options for both myopia and presbyopia, fundamentally transforming the way these conditions are managed.

What Is Driving the Growth of the Global Myopia and Presbyopia Treatment Market?

The growth in the global myopia and presbyopia treatment market is being driven by several key factors, including the rising prevalence of these vision disorders, the increasing demand for advanced and minimally invasive treatments, and technological innovations in eye care. One of the most significant growth drivers is the sharp rise in myopia cases globally, particularly among younger populations in urban areas. Factors such as increased screen time, digital device usage, and reduced time spent outdoors are contributing to an epidemic of myopia, especially in Asia-Pacific, where some regions report myopia prevalence rates exceeding 80%. This has led to an urgent need for treatments that not only correct but also slow the progression of myopia, fueling demand for products like Ortho-K lenses, atropine eye drops, and advanced contact lenses.

Another key driver is the aging global population, which is contributing to a growing number of presbyopia cases. As life expectancy increases, more people are seeking effective treatments for presbyopia to maintain their quality of life and independence. This demographic trend has led to a surge in demand for presbyopia-correcting options such as multifocal intraocular lenses (IOLs), presbyopia-correcting contact lenses, and surgical solutions like LASIK. Additionally, the rise of cosmetic eye care and lifestyle-based treatments is encouraging individuals to opt for long-term solutions that enhance their vision without the need for glasses, further driving market growth.

Technological advancements in the diagnosis and treatment of myopia and presbyopia are also significant growth factors. Innovations such as AI-powered diagnostic tools, minimally invasive surgical techniques, and advanced lens designs are improving treatment outcomes and making these options more accessible to a wider range of patients. Furthermore, the increasing availability of telemedicine services is expanding access to eye care, particularly in remote and underserved regions, where traditional eye care services may be limited. This is expected to further boost the adoption of advanced treatments for myopia and presbyopia as more people gain access to specialized care.

Lastly, rising healthcare expenditure and improved awareness about vision health are contributing to market growth. Governments and healthcare organizations are increasingly recognizing the importance of early detection and treatment of refractive errors to prevent long-term vision problems, leading to greater investment in eye health services and public awareness campaigns. The combination of these factors—rising prevalence, aging populations, technological innovation, and greater access to care—is driving the rapid growth of the global myopia and presbyopia treatment market, positioning it for significant expansion in the coming years.

Select Competitors (Total 51 Featured) -

  • AbbVie, Inc.
  • Alcon, Inc.
  • Bausch & Lomb, Inc.
  • Carl Zeiss Meditec AG
  • CooperVision, Inc.
  • EssilorLuxottica
  • Eyenovia
  • Johnson & Johnson Vision Care, Inc.
  • LENZ Therapeutics
  • Ocuphire Pharma, Inc.
Show more
Product Code: MCP24331

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Myopia and Presbyopia Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Myopia and Presbyopia Propels Demand for Treatment Solutions
    • Case Overview: Innovation in Contact Lens Technology Bodes Well for Market Expansion
    • Growing Awareness of Early Detection and Treatment Sets the Stage for Myopia Management
    • Focus on Digital Eye Strain from Increased Screen Time Spurs Demand for Myopia Treatments
    • Case Overview: Growth in Aging Population Expands Demand for Presbyopia Treatments
    • Technological Advancements in Multifocal Intraocular Lenses Propel Growth in Presbyopia Market
    • Rising Consumer Focus on Aesthetic Vision Correction Solutions Spurs Demand for Surgery
    • Increasing Focus on Pediatric Myopia Management Expands Opportunities for Preventative Treatments
    • Development of Eye Drop Solutions for Myopia and Presbyopia Bodes Well for Market Innovation
    • Case Overview: Technological Advancements in LASIK and SMILE Procedures Propel Market Growth
    • Expansion of Telemedicine and Online Eye Care Services Expands Access to Treatment Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Myopia and Presbyopia Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Myopia and Presbyopia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Myopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Myopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Myopia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Presbyopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Presbyopia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Presbyopia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • JAPAN
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • CHINA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • EUROPE
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Myopia and Presbyopia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • FRANCE
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • GERMANY
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • INDIA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Myopia and Presbyopia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030
  • AFRICA
    • Myopia and Presbyopia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Myopia and Presbyopia Treatment by Condition - Myopia and Presbyopia Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Myopia and Presbyopia Treatment by Condition - Percentage Breakdown of Value Sales for Myopia and Presbyopia for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!